Perimenopause Hormone Levels: Which Markers Shift First?

One month your period arrives exactly when expected. The next cycle is ten days longer, sleep feels lighter, and then everything seems to settle again. Perimenopause hormone levels often change like a moving pattern, not a switch from “normal” to “low.” That is why the first useful clue may be a change in cycle rhythm, while a single blood result still looks unremarkable.

Perimenopause is the transition leading up to the final menstrual period and extending through the following year. During this time, communication between the ovaries and the pituitary gland in the brain becomes less predictable. Follicle-stimulating hormone (FSH), estradiol and progesterone do not all move at the same speed or in one direction.

Bloodwork can provide context, especially when age, cycle timing, symptoms and medication are considered together. It cannot confirm or rule out perimenopause on its own. The most useful question is therefore not simply, “Is this value normal?” It is, “What pattern do these markers form, and when was the sample taken?”

First, how the hormone feedback loop works

It helps to know where the hormones come from. The pituitary gland, a small gland at the base of the brain, sends follicle-stimulating hormone (FSH) and luteinizing hormone (LH) to the ovaries. FSH supports the growth of an ovarian follicle, the small fluid-filled structure that contains an egg. As the follicle develops, the ovary produces estradiol. LH helps trigger ovulation. After ovulation, the emptied follicle forms a temporary structure that produces progesterone.

This is a feedback loop. Estradiol and another ovarian hormone called inhibin send information back to the brain. When the ovary is responding well, that feedback helps prevent the pituitary gland from releasing more FSH than is needed. Prolactin also comes from the pituitary gland, but it has a different role and is not one of the main signals driving this monthly loop.

During perimenopause, fewer ovarian follicles respond consistently. The feedback signal becomes less steady, so the pituitary gland may release more FSH in an effort to stimulate the ovaries. Estradiol can still remain within its usual range, or rise temporarily, because the ovary may still respond in that particular cycle (Su & Freeman, 2009).

Specialised markers of the remaining follicle pool, such as anti-Müllerian hormone (AMH) and inhibin B, may begin to change earlier. Earlier does not automatically mean more useful. AMH is mainly used to estimate ovarian reserve in fertility settings and does not show whether a symptom is caused by perimenopause. International staging criteria therefore place changes in menstrual cycle length at the centre, with hormone markers providing supporting context (Harlow et al., 2012).

FSH often rises first, but one result is not a verdict

FSH is often the first marker in a standard hormone panel to move upward. It is the pituitary gland’s signal asking the ovaries to recruit and mature a follicle. When ovarian feedback weakens, more signal may be needed to produce a response. In group data, early-follicular FSH can begin to rise years before the final menstrual period (Burger et al., 2002).

For an individual person, however, FSH can move back into the reference interval in the next cycle. An ovulatory cycle may show little increase, while an anovulatory cycle, one without ovulation, may show a much higher result. This mix is one reason early-follicular FSH readings overlap widely across reproductive stages (Burger, 2008).

Current European guidance reflects this uncertainty. In otherwise healthy people over 45 with a typical history, biochemical testing is not required to identify perimenopause. It can be considered between 40 and 45, and is important when ovarian insufficiency is suspected before 40. When FSH is measured, days 2 to 5 of the cycle provide the most comparable baseline, or it can be measured after a prolonged gap without a period (Lumsden et al., 2025).

Estradiol becomes unpredictable before it stays low

Estradiol is often described as if it simply declines throughout perimenopause. Early in the transition, the more accurate picture is fluctuation. Higher FSH stimulation can temporarily maintain or increase estradiol production. Another cycle may produce much less. A result inside the laboratory range therefore captures the day of the blood draw, not the stability of the wider pattern.

This is why FSH and estradiol are more informative as a pair. Higher FSH with preserved estradiol can fit an ovary that still responds, but needs a stronger signal. Higher FSH with lower estradiol can fit a lower-output cycle. Neither combination should be read without cycle day, age, recent bleeding pattern and medication context. Combined hormonal contraception and menopausal hormone therapy can change or suppress the body’s own pattern, so results taken during treatment answer a different question.

Progesterone tells a cycle story, but timing changes the meaning

Progesterone rises after ovulation. As ovulation becomes less consistent, more cycles have little or no luteal progesterone rise. This change is gradual, not immediate. In a longitudinal study of 511 women, nearly 88 percent of observed cycles still showed evidence of luteal activity five years before the final menstrual period. Within the final year, that figure had fallen to around 23 percent. Progesterone metabolite output declined slowly across the transition (Santoro et al., 2017).

The timing caveat is essential. Progesterone should be low during days 2 to 5, before ovulation. An early-follicular result is useful as part of a standardised baseline panel, but it cannot show whether progesterone rises adequately later in that cycle. If the clinical question is whether ovulation occurred, a clinician may choose a later, cycle-specific measurement instead.

This also explains why a cycle diary adds real value. Recording the first full day of bleeding, cycle length and whether the pattern is changing gives the laboratory result a timeline. For more detail on how cycle phase affects blood results, see Aware’s guide to female hormones and lab testing.

What LH and prolactin add to a perimenopause blood test

Luteinizing hormone (LH) is the second main signal sent from the pituitary gland to the ovaries. Its surge in the middle of the cycle helps trigger ovulation. LH may rise as ovarian feedback changes, but it is not a stand-alone marker of perimenopause. Measured early in the cycle, it adds context to FSH and estradiol rather than answering the question by itself.

Prolactin also comes from the pituitary gland, but it is useful for a different reason. It is not expected to shift first in perimenopause. A higher result can interfere with ovulation and make periods less predictable, so it may be a reason to discuss other possible explanations with a healthcare professional. Thyroid function, pregnancy where relevant, significant weight change, stress, medication and other health conditions may also affect cycles or produce overlapping symptoms. A sex hormone panel does not cover all of these possibilities.

Testosterone, sex hormone-binding globulin (SHBG) and dehydroepiandrosterone sulfate (DHEA-S) describe another part of the hormone picture. They show androgen levels and how much testosterone is bound in the blood, but they cannot tell you how close menopause is. For a broader explanation of what each female hormone marker contributes, see the complete women’s hormone blood test guide.

How to make hormone testing more useful

A blood test becomes more informative when it is treated as one piece of a timeline. If your periods are still occurring, a day 2 to 5 sample gives FSH, LH and estradiol a more comparable starting point. Count day 1 as the first full day of bleeding. If cycles are very long or absent, timing should be discussed with a healthcare professional.

Unexpected cycle changes before 40 should be assessed medically. The same applies to very heavy bleeding, bleeding between periods or after sex, or symptoms that concern you. These patterns should not simply be labelled perimenopause from an online article or a blood panel.

Perimenopause hormone levels, frequently asked